Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose GSK2269557 in COPD patients (PK, safety, sputum biomarkers)
2014-000313-31Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing GSK2269557 arm with Placebo arm (2 arms). Primary endpoint: Pharmacokinetic profile of repeat doses of GSK2269557 (Part A). Started Apr 2014; status: completed.
02
Drugs
nemiralisib
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-000313-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000313-31.